Close Menu

Themes of the day: public skepticism and high-tech gadgets. This story from the New York Times follows suit, delving into the story of Nabil Al-Hadithy, the hazardous waste manager of Berkeley, Calif., who succeeded in passing regulations governing companies that use or manufacture nanoparticles. According to the article:

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.

The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.

The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.

In PLOS this week: genome instability in Aicardi-Goutières Syndrome, introduction of SARS-CoV-2 to the Colombian Amazon, and more.